[Restrictive cardiomyopathy associated with heart failure]

Nihon Rinsho. 2007 May 28:65 Suppl 5:430-7.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Calcium Channel Blockers / therapeutic use
  • Cardiomyopathy, Restrictive* / complications
  • Cardiomyopathy, Restrictive* / diagnosis
  • Cardiomyopathy, Restrictive* / genetics
  • Cardiomyopathy, Restrictive* / therapy
  • Diagnostic Imaging
  • Diuretics / therapeutic use
  • Heart Failure / etiology*
  • Heart Failure / physiopathology
  • Humans
  • Mutation
  • Prognosis
  • Troponin I / genetics
  • Ventricular Myosins / genetics

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Calcium Channel Blockers
  • Diuretics
  • Troponin I
  • Ventricular Myosins